S
LXRX icon

SignatureFD’s Lexicon Pharmaceuticals LXRX Stock Holding History

SignatureFD’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-388
Closed -$287 – 3393
2024
Q4 		$287 Sell
388
-786
-67% -$947 ﹤0.01% 3196
2024
Q3 		$1.84K Hold
1,174
– – ﹤0.01% 2856
2024
Q2 		$1.97K Hold
1,174
– – ﹤0.01% 2758
2024
Q1 		$2.82K Sell
1,174
-437
-27% -$939 ﹤0.01% 2706
2023
Q4 		$2.46K Buy
+1,611
New +$1.92K ﹤0.01% 2710
2014
Q3 		– Sell
-1,857
Closed -$21K – 824
2014
Q2 		$21K Hold
1,857
– – 0.01% 354
2014
Q1 		$22K Hold
1,857
– – 0.01% 310
2013
Q4 		$23K Buy
+1,857
New +$29.5K 0.01% 333

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return